Table 3. The mean value comparing of patient clinical parameter of different DACT2 expression groups in myocardium of patients with valvular heart disease.
| Variable | Weak | Strong | P |
|---|---|---|---|
| EF (%) | 64.364±9.157 | 61.353±5.700 | 0.292 |
| LA (mm) | 63.818±17.634 | 52.059±22.030 | 0.149 |
| LVD (mm) | 50.364±10.698 | 52.765±9.203 | 0.532 |
| LVS (mm) | 31.909±4.763 | 34.941±6.805 | 0.210 |
| IVS (mm) | 9.636±1.362 | 10.029±2.294 | 0.614 |
| LVPW (mm) | 9.455±0.820 | 9.823±1.845 | 0.540 |
| RA (mm) | 65.182±13.423 | 52.353±11.581 | 0.012* |
| RV (mm) | 25.182±3.281 | 25.647±12.604 | 0.906 |
As long as the sample contained cells with DACT2 staining, the expression level was regarded as weak if mean density <0.004, strong if mean density ≥0.004. Student’s t-test was used for comparisons between 2 groups. *, P≤0.05.